Clinical Trials for Axsome Therapeutics

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Axsome Therapeutics

Clinical Trials (7)

Open-Label Safety Study of Solriamfetol in Subjects with Binge Eating Disorder

PHASE3Enrolling by invitation

300 participants

Started: Feb 20, 2025 · Completed: Dec 31, 2026

1 condition1 sponsor18 locations

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

PHASE3Recruiting

520 participants

Started: Aug 1, 2024 · Completed: Dec 31, 2026

2 conditions1 sponsor25 locations

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

PHASE2Recruiting

46 participants

Started: Jun 1, 2024 · Completed: Mar 1, 2027

2 conditions3 sponsors1 location

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

PHASE3Recruiting

450 participants

Started: Apr 26, 2024 · Completed: Dec 31, 2025

1 condition1 sponsor43 locations

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

PHASE4Recruiting

350 participants

Started: Dec 27, 2023 · Completed: Mar 31, 2026

1 condition1 sponsor40 locations

Solriamfetol and CBT-I in Patients With Insomnia Disorder

PHASE4Active, not recruiting

60 participants

Started: Jul 31, 2023 · Completed: Apr 30, 2026

1 condition2 sponsors1 location

SUNOSI® (Solriamfetol) Pregnancy Registry

1,731 participants

Started: Jul 31, 2019 · Completed: Sep 30, 2029

3 conditions1 sponsor2 locations